Yoshinoya Strengthens Rare Disease Pipeline with IntraBio Acquisition
· gurufocus.com
Japanese pharmaceutical company Yoshinoya has announced the acquisition of IntraBio, aiming to enhance its capabilities in rare disease research and development
Japanese pharmaceutical company Yoshinoya has announced the acquisition of IntraBio, aiming to enhance its capabilities in rare disease research and development...